BiomX (PHGE) Exchange Rate Effect (2021 - 2025)
BiomX (PHGE) posted Exchange Rate Effect of $20000.0 for Q4 2025, up 42.86% sequentially from $14000.0 in Q3 2025, and up 66.67% YoY from $12000.0 in Q4 2024.
BiomX (PHGE) Exchange Rate Effect (2021 - 2025) Analysis & Trends
BiomX has reported Exchange Rate Effect for 5 years, with the latest figure at $20000.0 in Q4 2025.
- Quarterly Exchange Rate Effect rose 66.67% year-over-year to $20000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $73000.0 (down 2.67% YoY) and the FY2025 annual result came in at $73000.0, up 7200.0% from the prior year.
- Exchange Rate Effect advanced to $20000.0 in Q4 2025 per PHGE's latest filing, from $14000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $83000.0 in Q2 2022 and troughed at -$42000.0 in Q2 2023.
- A 5-year average of $10105.3 and a median of $12000.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect jumped 566.67% in 2022, then tumbled 150.6% in 2023.
- Over 5 years, Exchange Rate Effect stood at -$23000.0 in 2021, then sank by 43.48% to -$33000.0 in 2022, then jumped by 230.3% to $43000.0 in 2023, then sank by 72.09% to $12000.0 in 2024, then soared by 66.67% to $20000.0 in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $20000.0, $14000.0, and $36000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Sep 30, 2024 | 35,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | -42,000.00 |
| Jun 30, 2023 | -42,000.00 |